| Cash Flow | 2025-09-26 | 2025-06-27 |
|---|---|---|
| Proceeds from vested restricted and performance stock units | 3 | 2 |
| Net cash provided by (used in) financing activities | -4,505 | -5,488 |
| Effect of exchange rate changes on cash and cash equivalents | 1,063 | 972 |
| Increase (decrease) in cash and cash equivalents | 31,996 | 22,972 |
| Cash and cash equivalents at beginning of period | 144,159 | - |
| Cash and cash equivalents at end of period | 176,155 | - |
STAAR SURGICAL CO (STAA)
STAAR SURGICAL CO (STAA)